Madrigal Pharmaceuticals (MDGL) Retained Earnings (2010 - 2026)
Madrigal Pharmaceuticals (MDGL) reported Retained Earnings of -$2.2 billion for Q1 2026, down 16.5% year-over-year from -$2.6 billion in Q1 2025, and down 250374.91% on a QoQ basis from $873000.0 in Q4 2025.
Madrigal Pharmaceuticals (MDGL) has 17 years of Retained Earnings data on file, last reported at -$2.2 billion in Q1 2026.
- Quarterly Retained Earnings fell 16.5% year-over-year to -$2.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.2 billion (down 16.5% YoY) and the FY2025 annual result came in at $873000.0, up 86.54% from the prior year.
- Retained Earnings slipped to -$2.2 billion in Q1 2026 per MDGL's latest filing, from $873000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $1.3 million in Q3 2024 and bottomed at -$2.2 billion in Q1 2026.
- The 5-year median for Retained Earnings is -$962.7 million (2022), against an average of -$815.1 million.
- Peak annual rise in Retained Earnings reached 100.1% in 2024, while the deepest fall reached 1725284.88% in 2024.
- Tracing MDGL's Retained Earnings over 5 years: stood at -$962.7 million in 2022, then slumped by 38.81% to -$1.3 billion in 2023, then surged by 100.04% to $468000.0 in 2024, then soared by 86.54% to $873000.0 in 2025, then slumped by 250374.91% to -$2.2 billion in 2026.
- Per Business Quant, the three latest MDGL Retained Earnings figures stand at -$2.2 billion (Q1 2026), $873000.0 (Q4 2025), and -$2.0 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Madrigal Pharmaceuticals | 14.44 Bn | 14.20 Bn | - | -2.18 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.18 Bn |
| Dec 31, 2025 | 873,000.00 |
| Sep 30, 2025 | -2.03 Bn |
| Jun 30, 2025 | 1.11 Mn |
| Mar 31, 2025 | -1.88 Bn |
| Dec 31, 2024 | 468,000.00 |
| Sep 30, 2024 | 1.27 Mn |
| Jun 30, 2024 | -1.64 Bn |
| Mar 31, 2024 | -1.48 Bn |
| Dec 31, 2023 | -1.34 Bn |
| Sep 30, 2023 | -1.22 Bn |
| Jun 30, 2023 | -1.13 Bn |
| Mar 31, 2023 | -86,000.00 |
| Dec 31, 2022 | -962.66 Mn |
| Sep 30, 2022 | -237,000.00 |
| Jun 30, 2022 | -447,000.00 |
| Mar 31, 2022 | -402,000.00 |
| Dec 31, 2021 | -80,000.00 |
| Sep 30, 2021 | -602.80 Mn |
| Jun 30, 2021 | 15,000.00 |
| Mar 31, 2021 | -478.01 Mn |
| Dec 31, 2020 | -425.50 Mn |
| Sep 30, 2020 | 421,000.00 |
| Jun 30, 2020 | -308.40 Mn |
| Mar 31, 2020 | -259.40 Mn |
| Dec 31, 2019 | -223.22 Mn |
| Sep 30, 2019 | -195.48 Mn |
| Jun 30, 2019 | -174.05 Mn |
| Mar 31, 2019 | 178,000.00 |
| Dec 31, 2018 | -139.27 Mn |
| Sep 30, 2018 | -143,000.00 |
| Jun 30, 2018 | -43,000.00 |
| Mar 31, 2018 | -174,000.00 |
| Dec 31, 2017 | -106.46 Mn |
| Sep 30, 2017 | -98.02 Mn |
| Jun 30, 2017 | 36,000.00 |
| Mar 31, 2017 | -81.31 Mn |
| Dec 31, 2016 | 25,000.00 |
| Sep 30, 2016 | -67.56 Mn |
| Jun 30, 2016 | -716.15 Mn |
| Mar 31, 2016 | -712.77 Mn |
| Dec 31, 2015 | -48.92 Mn |
| Sep 30, 2015 | -695.71 Mn |
| Jun 30, 2015 | -6,000.00 |
| Mar 31, 2015 | 6,000.00 |
| Dec 31, 2014 | -637.57 Mn |
| Sep 30, 2014 | 11,000.00 |
| Jun 30, 2014 | -597.26 Mn |
| Mar 31, 2014 | 4,000.00 |
| Dec 31, 2013 | -551.41 Mn |
| Sep 30, 2013 | 6,000.00 |
| Jun 30, 2013 | 9,000.00 |
| Mar 31, 2013 | -481.95 Mn |
| Dec 31, 2012 | 2,000.00 |
| Sep 30, 2012 | -443.10 Mn |
| Jun 30, 2012 | -428.10 Mn |
| Mar 31, 2012 | -413.48 Mn |
| Dec 31, 2011 | 3,000.00 |
| Sep 30, 2011 | -387.69 Mn |
| Jun 30, 2011 | -374.95 Mn |
| Dec 31, 2010 | -3,000.00 |